Lyra Therapeutics, Inc. (LYRA)
NASDAQ: LYRA · Real-Time Price · USD
0.1201
-0.0062 (-4.91%)
At close: Apr 1, 2025, 4:00 PM
0.1239
+0.0038 (3.20%)
After-hours: Apr 1, 2025, 7:55 PM EDT

Lyra Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2018
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2018
Market Capitalization
81427510057147
Upgrade
Market Cap Growth
-95.09%-95.09%175.61%76.26%-61.52%-
Upgrade
Enterprise Value
2-3179-9068
Upgrade
Last Close Price
0.130.215.243.144.3611.40
Upgrade
PS Ratio
5.368.81176.7973.32198.95-
Upgrade
PB Ratio
0.711.173.081.241.651.98
Upgrade
P/TBV Ratio
1.171.173.081.241.651.98
Upgrade
EV/Sales Ratio
1.39-115.00-0.97-
Upgrade
Debt / Equity Ratio
2.972.970.300.030.040.03
Upgrade
Asset Turnover
0.020.020.010.020.00-
Upgrade
Quick Ratio
3.213.215.246.772.5115.27
Upgrade
Current Ratio
3.413.415.356.972.6315.54
Upgrade
Return on Equity (ROE)
-184.99%-184.99%-73.67%-96.08%-79.98%-54.09%
Upgrade
Return on Assets (ROA)
-36.33%-36.33%-32.43%-41.70%-40.18%-28.98%
Upgrade
Return on Capital (ROIC)
-46.78%-46.78%-41.11%-57.89%-48.38%-31.70%
Upgrade
Earnings Yield
-1121.14%-691.58%-22.76%-55.31%-76.74%-15.02%
Upgrade
FCF Yield
-868.13%-535.50%-23.36%-43.58%-51.51%-15.55%
Upgrade
Buyback Yield / Dilution
-30.74%-30.74%-64.72%-132.83%-51.17%-4150.62%
Upgrade
Updated Mar 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q